No human clinical trials have been conducted specifically examining corynoxine's health effects. Available research consists primarily of in vitro mechanistic studies and traditional use documentation. The alkaloid has been identified in Uncaria rhynchophylla extracts used in some traditional medicine studies, but corynoxine's individual contributions remain unquantified. Current evidence is insufficient to support specific therapeutic claims.
Origin
Corynoxine is an indole alkaloid isolated primarily from the leaves of Uncaria rhynchophylla (Gou-teng), a plant used in traditional Chinese medicine, though it has also been identified in kratom (Mitragyna speciosa) extracts. It belongs to the class of monoterpenoid indole alkaloids, specifically oxindole derivatives. Extraction typically involves acidified water or organic solvents like methanol, followed by purification via chromatography.
Potential benefits
• No clinically proven health benefits - no human clinical trials identified in research • Potential opioid receptor activity - limited mechanistic data suggests possible similarities to related alkaloids • Traditional medicine association - source plant used in Chinese medicine but specific benefits not documented • Structural similarity to corynantheidine - related compound studied for opioid activity • Research gap - no evidence-based benefits can be claimed from available data
How it works
Corynoxine demonstrates potential activity at opioid receptors, though specific binding affinities remain poorly characterized. Limited mechanistic studies suggest this oxindole alkaloid may modulate neurotransmitter pathways similar to other Uncaria alkaloids. The compound's molecular interactions with dopaminergic and cholinergic systems require further investigation.
What the research says
No human clinical trials, randomized controlled trials, or meta-analyses specifically on corynoxine were identified in the available research. The research focuses primarily on extraction methods and preclinical analysis of kratom alkaloids, with no PubMed PMIDs provided for corynoxine clinical data.
Safety and interactions
Safety data for isolated corynoxine is extremely limited with no established dosage guidelines or toxicity profiles. Potential interactions with opioid medications or central nervous system drugs remain unknown due to lack of pharmacokinetic studies. Pregnancy and breastfeeding safety has not been evaluated. Individuals taking prescription medications should consult healthcare providers before using corynoxine-containing supplements.
Suggested use
No clinically studied dosage ranges, forms, or standardization details for corynoxine are available as no clinical studies have been conducted. Consult a healthcare provider before starting any new supplement.
Frequently asked questions
What is corynoxine found in naturally?
Corynoxine is naturally found in Uncaria rhynchophylla, a traditional Chinese medicinal plant also known as Gou Teng. This oxindole alkaloid is one of several bioactive compounds present in the plant's hooks and stems.
Does corynoxine have opioid effects?
Limited research suggests corynoxine may interact with opioid receptors, but specific binding affinities and clinical effects remain uncharacterized. No human studies have confirmed opioid-like effects or therapeutic benefits.
Is corynoxine the same as rhynchophylline?
No, corynoxine and rhynchophylline are distinct alkaloids both found in Uncaria rhynchophylla. While both are oxindole alkaloids with potential bioactivity, they have different molecular structures and may have varying pharmacological properties.
What dosage of corynoxine is safe?
No safe dosage range has been established for corynoxine due to lack of human clinical trials and safety studies. Without toxicity data or pharmacokinetic research, appropriate dosing guidelines cannot be determined.
Can corynoxine help with neurological conditions?
Currently, no clinical evidence supports corynoxine's use for neurological conditions. While the source plant Uncaria rhynchophylla has traditional neurological applications, corynoxine's individual therapeutic effects remain unproven in human studies.
Does corynoxine have any known side effects or adverse effects?
Limited human safety data exists for corynoxine, as it has not undergone rigorous clinical testing in humans. Based on its structural similarity to other alkaloids with opioid activity, potential side effects could theoretically include dizziness, nausea, or constipation, though these have not been formally documented in controlled studies. Anyone considering corynoxine supplementation should consult a healthcare provider due to the lack of established safety profiles.
References
This article is educational and is not medical advice. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use.
